Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex, will present on Tuesday, March 16th, at 8:30 a.m. PDT at the 22nd Annual Roth Capital OC Growth Stock Conference taking place at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.
Contacts:
Anthony S. Marucci, 781-433-0771
President
and CEO
or
Celldex Therapeutics, Inc.
Avery W. Catlin,
781-433-0771
Chief Financial Officer
IR@celldextherapeutics.com
or
For
Media:
BMC Communications Group
Matthew Driscoll,
212-477-9007 x20
mdriscoll@bmccommunications.com